Cheniere Energy’s valuation seems reasonable, but a declining natural-gas market could hurt the company's revenue.
Marathon Petroleum won’t necessarily benefit from lower oil prices if the spread between Brent and WTI remains low.
Shares of BP have fallen due to low oil prices, lower-than-expected earnings, falling profits from Rosneft and the risk related to the 2010 oil spill.
Chesapeake Energy experiences a high disparity between its realized natural gas prices and market prices. This gap could keep down its revenue from natural gas production.
Anadarko Petroleum reached its quarterly goals and may become a buyout target for the big oil companies.
SunPower released its third quarter earnings report -- and its lower profit margin didn't impress investors.
The shares get a boost from the company's third-quarter report, despite disappointing earnings.
And the company has a new cancer drug on the market, plus a new insulin that should be approved in Europe.
Bank of Israel reduced its cash rate to a historic low of 0.25%. This decision could have an adverse impact on the dividend payment of Teva Pharmaceutical Industries.
Ongoing conflicts and sales in the Middle East could boost Lockheed Martin’s revenue in the near term.